| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Fuller RW, Hines CW, Mill... |
Lowering of Brain Serotonin Levels by Chloramphetamines |
Biochem Pharmacol |
1965 |
| Barfknecht CF, Nichols DE |
Potential psychotomimetics, Bromomethoxyamphetamines |
J Med Chem |
1971 |
| Barfknecht CF, Nichols DE |
Potential psychotomimetics. Bromomethoxyamphetamines |
J Med Chem |
1971 |
| Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Murdock JE, Shulgin AT |
A novel illicit amphetamine laboratory |
Microgram |
1978 |
| Schmidt CJ, Sonsalla PK, ... |
Methamphetamine-induced depression of monoamine synthesis in the rat: ... |
J Neurochem |
1985 |
| Seymour RB, Wesson DR, Sm... |
Editor's Introduction |
J Psychoactive Drugs |
1986 |
| Dowling GP, McDonough ET ... |
'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... |
JAMA |
1987 |
| Stone DM, Merchant KM, Ha... |
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... |
Neuropharmacology |
1987 |
| Buchanan JF, Brown CR |
'Designer drugs'. A problem in clinical toxicology |
Med Toxicol Adverse ... |
1988 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Schmidt CJ, Taylor VL |
Direct central effects of acute methylenedioxymethamphetamine on serot... |
Eur J Pharmacol |
1988 |
| Cozzi NV, Sievert MK, Shu... |
Methcathinone and 2-methylamino-1-(3,4-methylenedioxyphenyl)propan-1-o... |
Soc. Neurosci. Abs |
1988 |
| Fitzgerald RL, Blanke RV,... |
Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxym... |
J Chromatogr |
1989 |
| Johnson M, Stone DM, Bush... |
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... |
Eur J Pharmacol |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Stone DM, Hanson GR, Gibb... |
In vitro reactivation of rat cortical tryptophan hydroxylase following... |
J Neurochem |
1989 |
| Gibb JW, Stone DM, Johnso... |
Role of dopamine in the neurotoxicity induced by amphetamines and rela... |
NIDA Res Monogr |
1989 |
| Callaway CW, Wing LL, Gey... |
Serotonin release contributes to the locomotor stimulant effects of 3,... |
J Pharmacol Exp Ther |
1990 |
| Nash JF, Meltzer HY, Gude... |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalan... |
J Neurochem |
1990 |
| Schmidt CJ, Abbate GM, Bl... |
Selective 5-hydroxytryptamine2 receptor antagonists protect against th... |
J Pharmacol Exp Ther |
1990 |
| Schmidt CJ, Black CK, Tay... |
Antagonism of the neurotoxicity due to a single administration of meth... |
Eur J Pharmacol |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Johnson MP, Frescas SP, O... |
Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... |
J Med Chem |
1991 |
| Lim HK, Foltz RL |
In vivo formation of aromatic hydroxylated metabolites of 3,4-(methyle... |
Biol Mass Spectrom |
1991 |
| Pan HS, Wang RY |
The action of (+/-)-MDMA on medial prefrontal cortical neurons is medi... |
Brain Res |
1991 |
| Schechter MD |
Effect of serotonin depletion by p-chlorophenylalanine upon discrimina... |
Gen Pharmacol |
1991 |
| Schmidt CJ, Taylor VL, Ab... |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-m... |
J Pharmacol Exp Ther |
1991 |
| Hanson GR, Bunker CF, Joh... |
Response of monoaminergic and neuropeptide systems to 4-methylaminorex... |
Eur J Pharmacol |
1992 |
| Preston A |
Pointing out the Risk |
Nursing Times |
1992 |
| Schmidt CJ, Black CK, Tay... |
The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-... |
Eur J Pharmacol |
1992 |
| Schmidt CJ, Fadayel GM, S... |
5-HT2 receptors exert a state-dependent regulation of dopaminergic fun... |
Eur J Pharmacol |
1992 |
| Singarajah C, Lavies NG |
An overdose of ecstasy: A role for dantrolene |
Anaesthesia |
1992 |
| Zhao ZY, Castagnoli N Jr,... |
Synthesis and neurotoxicological evaluation of putative metabolites of... |
Chem Res Toxicol |
1992 |
| Bohn M, Bohn G, Blaschke ... |
Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetam... |
Int J Legal Med |
1993 |
| Huang X, Nichols DE |
5-HT2 receptor-mediated potentiation of dopamine synthesis and central... |
Eur J Pharmacol |
1993 |
| Maxwell DL, Polkey MI, He... |
Hyponatraemia and catatonic stupor after taking 'ecstasy' |
BMJ |
1993 |
| Rothwell PM, Grant R |
Cerebral venous sinus thrombosis induced by 'ecstasy' |
J Neurol Neurosurg P... |
1993 |
| Shiue CY, Shiue GG, Rysav... |
Fluorine-18 and carbon-11 labeled amphetamine analogs--synthesis, dist... |
Nucl Med Biol |
1993 |
| McDowell DM, Kleber HD |
MDMA: Its history and pharmacology |
Psychiatric Annals |
1994 |
| Marona-Lewicka D, Nichols... |
Behavioral effects of the highly selective serotonin releasing agent 5... |
Eur J Pharmacol |
1994 |
| McCoy EP, Renfrew C, John... |
Malignant hyperpyrexia in an MDMA ('Ecstasy') abuser |
Ulster Med J |
1994 |
| Schmidt CJ, Sullivan CK, ... |
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increa... |
J Neurochem |
1994 |
| Steele TD, McCann UD, Ric... |
3,4-Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): pharmacology and ... |
Addiction |
1994 |
| White SR, Duffy P, Kaliva... |
Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firi... |
Neuroscience |
1994 |
| Bryden AA, Rothwell PJ, O... |
Urinary retention with misuse of 'ecstasy' |
BMJ |
1995 |
| Green AR, Cross AJ, Goodw... |
Review of the pharmacology and clinical pharmacology of 3,4-methylened... |
Psychopharmacology (... |
1995 |
| Poblete JC, Azmitia EC |
Activation of glycogen phosphorylase by serotonin and 3,4-methylenedio... |
Brain Res |
1995 |
| Miller RT, Serrine SL, Mo... |
Metabolism of 5-(Glutathion-S-yl)-a-methyldopamine Following Intracere... |
Chem Res Toxicol |
1995 |
| Miller RT, Lau SS, Monks ... |
Effects of intracerebroventricular administration of 5-(glutathion-S-y... |
Chem Res Toxicol |
1996 |
| Gudelsky GA, Nash JF |
Carrier-mediated release of serotonin by 3,4-methylenedioxymethampheta... |
J Neurochem |
1996 |
| Lin LY, Fujimoto M, Diste... |
Selective mechanism-based inactivation of rat CYP2D by 4-allyloxymetha... |
J Pharmacol Exp Ther |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Gifford AN, Minabe Y, Too... |
Examination of the action of 3,4-methylenedioxymethamphetamine on rat ... |
Synapse |
1996 |
| Geyer MA |
Serotonergic functions in arousal and motor activity |
Behav Brain Res |
1996 |
| Obradovic T, Imel KM, Whi... |
Methylenedioxymethamphetamine-induced inhibition of neuronal firing in... |
Neuroscience |
1996 |
| Taraska T, Finnegan KT |
Nitric oxide and the neurotoxic effects of methamphetamine and 3,4-met... |
J Pharmacol Exp Ther |
1997 |
| Brauer RB, Heidecke CD, N... |
Liver transplantation for the treatment of fulminant hepatic failure i... |
Transpl Int |
1997 |
| Zheng Y, Laverty R |
Role of brain nitric oxide in (+/-)3,4-methylenedioxymethamphetamine (... |
Brain Res |
1998 |
| Muck-Seler D, Takahashi S... |
The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT syn... |
Brain Res |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Sabol KE, Seiden LS |
Reserpine attenuates D-amphetamine and MDMA-induced transmitter releas... |
Brain Res |
1998 |
| Cozzi NV, Shulgin AT, Ruo... |
Methcathinone (MCAT) and 2-methylamino-1-(3,4-methylenedioxyphenyl)pro... |
Amer. Chem. Soc. Div... |
1998 |
| Stein DJ, Rink J |
Effects of 'Ecstasy' blocked by serotonin reuptake inhibitors |
J Clin Psychiatry |
1999 |
| Westwood SC, Hanson GR |
Effects of stimulants of abuse on extrapyramidal and limbic neuropepti... |
J Pharmacol Exp Ther |
1999 |
| Nishisawa S, Mzengeza S, ... |
Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin ... |
Neurochem Int |
1999 |
| Navarro JF, Maldonado E |
Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in ago... |
Prog Neuropsychophar... |
1999 |
| Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
| Erdtmann-Vourliotis M, Ma... |
Acute injection of drugs with low addictive potential (delta(9)-tetrah... |
Brain Res Mol Brain ... |
1999 |
| McFee RB, Mofenson HC, Ca... |
Dextromethorphan: Another 'Ecstasy'? |
Arch Fam Med |
2000 |
| de la Torre R, Farré M, O... |
Non-linear pharmacokinetics of MDMA (`ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| de la Torre R, Farre M, O... |
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans |
Br J Clin Pharmacol |
2000 |
| Aalberg L, DeRuiter J, No... |
Chromatographic and Mass Spectral Methods of Identification for the Si... |
J Chromatogr Sci |
2000 |
| Christophersen AS |
Amphetamine designer drugs - an overview and epidemiology |
Toxicol Lett |
2000 |
| Kuhn DM, Geddes TJ |
Molecular footprints of neurotoxic amphetamine action [In Process Cita... |
Ann N Y Acad Sci |
2000 |
| Kavanagh P, Dunne J, Feel... |
Phenylalkylamine abuse among opiate addicts attending a methadone trea... |
Addict Biol |
2001 |
| Maldonado E, Navarro JF |
Mdma (‘ecstasy’) exhibits an anxiogenic-like activity in social encoun... |
Pharmacological Rese... |
2001 |
| Colado MI, Camarero J, Me... |
A study of the mechanisms involved in the neurotoxic action of 3,4- me... |
Br J Pharmacol |
2001 |
| Stuerenburg HJ, Petersen ... |
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and... |
Neuroendocrinol Lett |
2002 |
| O'Shea E, Easton N, Fry J... |
Protection against 3,4-methylenedioxymethamphetamine-induced neurodege... |
J Neurochem |
2002 |
| Boot BP, Mechan AO, McCan... |
MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentratio... |
Eur J Pharmacol |
2002 |
| Lebsanft HB, Mayerhofer A... |
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unila... |
J Neural Transm |
2003 |
| Dumasia MC |
Identification of some N-hydroxylated metabolites of +/--3,4-methylene... |
Xenobiotica |
2003 |
| Halpern JH |
Hallucinogens: an update |
Curr Psychiatry Rep |
2003 |
| Easton N, Fry J, O'Shea E... |
Synthesis, in vitro formation, and behavioural effects of glutathione ... |
Brain Res |
2003 |
| Dafters RI, Biello SM |
The effect of 3,4-methylenedioxymethamphetamine ('Ecstasy') on seroton... |
Neurosci Lett |
2003 |
| Moyano S, Frechilla D, De... |
NMDA receptor subunit and CaMKII changes in rat hippocampus induced by... |
Psychopharmacology (... |
2004 |
| Garcia-Osta A, Del Rio J,... |
Increased CRE-binding activity and tryptophan hydroxylase mRNA express... |
Brain Res Mol Brain ... |
2004 |
| Segura M, Farre M, Pichin... |
Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetami... |
Clin Pharmacokinet |
2005 |
| Casteele SR, Bouche MP, V... |
LC-MS/MS in the elucidation of an isomer of the recreational drug meth... |
J Sep Sci |
2005 |
| Burchett SA, Hicks TP |
The mysterious trace amines: protean neuromodulators of synaptic trans... |
Prog Neurobiol |
2006 |
| Freudenmann RW, Oxler F, ... |
The origin of MDMA (ecstasy) revisited: the true story reconstructed f... |
Addiction |
2006 |
| Freudenmann RW, Oxler F, ... |
The origin of MDMA (ecstasy) revisited: the true story reconstructed f... |
Addiction |
2006 |
| Capela JP, Macedo C, Bran... |
Neurotoxicity mechanisms of thioether ecstasy metabolites |
Neuroscience |
2007 |
| Silins E, Copeland J, Dil... |
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use o... |
Aust N Z J Psychiatr... |
2007 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Ambrose JB, Bennett HD, L... |
Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingest... |
Neurologist |
2010 |
| Winstock AR, Mitcheson LR... |
Mephedrone, new kid for the chop? |
Addiction |
2010 |
